Accumulating evidence has shown that PRMT5 is the ectopic expression in many types of human cancer and regulates cell metabolism, including lung cancer, pancreatic cancer, breast cancer, leukemia, lymphoma, glioblastoma, prostate cancer, and bladder cancer [5, 6]. Here, PRMT5 is linked to prostate carcinoma.